RAYMOND L. WOOSLEY, M.D., PH.D. - Corporate Board Profile

Oruka Therapeutics, Inc.

Filing Date	Source Excerpt
2013-08-01	Dr. Woosley, age 70, was appointed to the ARCA Board of Directors in July 2013. ... Dr. Woosley is an appropriate member of the Company 27s Board of Directors, given his expertise and experience in cardiovascular clinical pharmacology, anti-arrhythmic therapeutics, pharmacogenetic drug development and therapeutic regulatory approval. ... The Compensation Committee is currently composed of two directors: Dr. Linda Grais (chair) and Dr. Raymond Woosley. ... The Nominating and Corporate Governance Committee is currently composed of two directors, Dr. Grais and Dr. Woosley.
2014-04-15	Dr. Woosley, age 71, was appointed to the ARCA Board of Directors in July 2013. ... Dr. Woosley is an appropriate member of the Company 27s Board of Directors, given his expertise and experience in cardiovascular clinical pharmacology, anti-arrhythmic therapeutics, pharmacogenetic drug development and therapeutic regulatory approval. ... The Audit Committee is currently composed of three directors: Mr. Conway (chair), Mr. Mitchell and Dr. Woosley. ... The Compensation Committee is currently composed of three directors: Mr. Robert Conway, Dr. Linda Grais (chair) and Dr. Raymond Woosley. ... The Nominating and Corporate Governance Committee is currently composed of three directors, Dr. Grais, Mr. Mitchell and Dr. Woosley. ... Dr. Woosley joined the Company 27s Board of Directors on July 26, 2013. ... The aggregate number of option awards outstanding at December 31, 2013 for Dr. Woosley was 19,463 shares, of which 5,684 shares were fully vested. ... The following table shows for the fiscal year ended December 31, 2013 certain information with respect to the compensation of all non-employee directors of the Company: ... Raymond L. Woosley ... Total($) 29,888.
2015-04-14	Dr. Woosley, age 72, was appointed to the ARCA Board of Directors in July 2013. Dr. Woosley is currently the President Emeritus, of the Critical Path Institute (C-Path), a non-profit, public-private partnership with the Federal Food and Drug Administration, of which he was a founder in November 2004, and where he served as President, Chief Executive Officer and Chairman of the Board from 2005 to 2011. Since 2012, Dr. Woosley has also been the Director of CredibleMeds Worldwide, an independent, nonprofit research and education organization. Since 2001, Dr. Woosley has also been a Professor of Medicine and Pharmacology at The University of Arizona Health Sciences Center (UAHSC), and, since 2012, Professor Emeritus, where he was also Vice President for Health Sciences from 2001 to 2005, and Dean of the College of Medicine from 2001 to 2002. From 1988 to 2001, Dr. Woosley was a professor of medicine at the Georgetown University School of Medicine, where he was also Director of the Institute of Cardiovascular Sciences from 1994 to 2000, and Division Chief, Clinical Pharmacology, in the Department of Medicine from 1988 to 1994. Dr. Woosley earned his Ph.D. in Pharmacology from the University of Louisville and his M.D. from the University of Miami. Dr. Woosley’s research has been published in over 265 peer-reviewed publications and 50 book chapters. Dr. Woosley is an appropriate member of the Company’s Board of Directors, given his expertise and experience in cardiovascular clinical pharmacology, anti-arrhythmic therapeutics, pharmacogenetic drug development and therapeutic regulatory approval. Director Compensation for fiscal 2014: $58,054.
2016-04-27	Dr. Woosley, age 73, was appointed to the Board of Directors in July 2013. ... The Audit Committee is currently composed of three directors: Mr. Conway (chair), Mr. Mitchell and Dr. Woosley. ... The Compensation Committee is currently composed of three directors: Mr. Robert Conway, Dr. Linda Grais (chair) and Dr. Raymond Woosley. ... The Nominating and Corporate Governance Committee is currently composed of three directors, Dr. Grais, Mr. Mitchell and Dr. Woosley (chair). ... Director Compensation for fiscal 2015: Raymond L. Woosley, M.D. Fees Earned or Paid in Cash ($) 50,000, Option Awards ($) 3,645, Total ($) 53,645.
2017-04-21	Dr. Woosley, age 74, was appointed to the Board of Directors in July 2013. ... In the fiscal year ended December 31, 2016, the Audit Committee was composed of three directors: ... Dr. Woosley left the Audit Committee, and Dr. Grais was appointed as a member of, the Audit Committee. ... The Compensation Committee is currently composed of three directors: Mr. Conway, Dr. Grais (chair) and Dr. Woosley. ... The Nominating and Corporate Governance Committee was composed of three directors: Dr. Grais, Mr. Mitchell and Dr. Woosley (chair). ... Director Compensation for Dr. Woosley for fiscal 2016 was $74,979.
2018-04-18	Dr. Woosley, age 75, was appointed to the Board of Directors in July 2013. Dr. Woosley is currently Professor of Medicine and Co-Director of the Division for Data Analytics and Decision Support in the Department of Medicine of the University of Arizona, College of Medicine in Phoenix. Since 2012, Dr. Woosley has served as the Director of the Arizona Center for Education and Research on Therapeutics (AzCERT), an independent, nonprofit research and education organization. He is also President Emeritus of the Critical Path Institute (C-Path), a non-profit, public-private partnership with the U.S. Food and Drug Administration, of which he was a founder in November 2004, and where he served as President, Chief Executive Officer and Chairman of the board of directors from 2005 to 2011. Since 2001, Dr. Woosley has also been a Professor of Medicine and Pharmacology at The University of Arizona Health Sciences Center in Tucson, AZ, and, since 2012, Professor Emeritus, where he was also Vice President for Health Sciences from 2001 to 2005, and Dean of the College of Medicine from 2001 to 2002. From 1988 to 2001, Dr. Woosley was a professor of medicine at the Georgetown University School of Medicine, where he was also Director of the Institute of Cardiovascular Sciences from 1994 to 2000, and Division Chief, Clinical Pharmacology, in the Department of Medicine from 1988 to 1994. From 1976 to 1988 he was a member of the faculty of Vanderbilt University where he rose to the rank of Professor of Medicine and Pharmacology and Associate Director of the NIH funded General Clinical Research Center. Dr. Woosley earned his Ph.D. in Pharmacology from the University of Louisville and his M.D. from the University of Miami. Dr. Woosley’s research has been published in over 312 peer-reviewed publications and 52 book chapters. We believe Dr. Woosley is an appropriate member of the Board of Directors, given his expertise and experience in cardiovascular medicine and clinical pharmacology, arrhythmia therapeutics, pharmacogenetic drug development and therapeutic regulatory science. Director Compensation For fiscal year ended December 31, 2017, Dr. Woosley received $50,000 in fees earned or paid in cash and $12,220 in option awards, totaling $62,220.
2019-10-25	Dr. Woosley, age 76, was appointed to the Board of Directors in July 2013. ... The Compensation Committee is currently composed of three directors: Mr. Conway, Dr. Grais (chair) and Dr. Woosley. ... The Nominating and Corporate Governance Committee is composed of three directors: Dr. Hove, Mr. Mitchell and Dr. Woosley (chair). ... Director Compensation for Fiscal 2018 ... Raymond L. Woosley ... $54,640.
2020-10-28	Raymond L. Woosley, M.D., Ph.D. Dr. Woosley, age 78, was appointed to the Board of Directors in July 2013. ... The Compensation Committee is currently composed of three directors: Mr. Conway, Dr. Grais (chair) and Dr. Woosley. ... Director Compensation for Fiscal 2019 shows Dr. Woosley received $50,000 in cash fees.
2021-04-21	Dr. Woosley, age 78, was appointed to the Board of Directors in July 2013. ... We believe Dr. Woosley is an appropriate member of the Board of Directors, given his expertise and experience in cardiovascular clinical pharmacology, anti-arrhythmic therapeutics, pharmacogenetic drug development and therapeutic regulatory approval. ... Compensation Committee of the Board of Directors, or the Compensation Committee, is currently composed of three directors: Mr. Conway, Dr. Grais (chair) and Dr. Woosley. ... The Nominating and Corporate Governance Committee is composed of three directors: Dr. Hove, Mr. Mitchell and Dr. Woosley (chair). ... The Board of Directors has three standing committees: The Audit Committee, the Compensation Committee, and the Nominating and Corporate Governance Committee. ... Director Compensation for Fiscal 2020 ... Raymond L. Woosley, M.D. ... $50,000 ...
2022-11-03	Dr. Woosley, age 79, was appointed to the Board of Directors in July 2013. ... The Compensation Committee of the Board of Directors, or the Compensation Committee, is currently composed of three directors: Mr. Conway, Dr. Grais (chair) and Dr. Woosley. ... The Nominating and Corporate Governance Committee of the Board of Directors, or the Nominating and Corporate Governance Committee, is composed of three directors: Dr. Hove, Mr. Mitchell and Dr. Woosley (chair). ... Director Compensation for Fiscal 2021 ... Raymond L. Woosley, M.D. ... Fees Earned or Paid in Cash ($) 53,750 ... Option Awards ($) 39,187 ... Total ($) 92,937.
2023-12-19	Dr. Woosley, age 81, was appointed to the Board of Directors in July 2013. ... He serves on the Audit Committee and Compensation Committee. Director compensation for 2022 was $66,336.